BioSyent Inc. (OTCMKTS:BIOYF) Sees Large Increase in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the recipient of a significant increase in short interest in September. As of September 30th, there was short interest totalling 1,900 shares, an increase of 58.3% from the September 15th total of 1,200 shares. Based on an average daily trading volume, of 1,600 shares, the days-to-cover ratio is presently 1.2 days.

BioSyent Stock Performance

Shares of OTCMKTS:BIOYF opened at $7.75 on Friday. BioSyent has a 52-week low of $5.65 and a 52-week high of $8.90. The business has a fifty day moving average of $7.79 and a two-hundred day moving average of $7.14.

BioSyent Increases Dividend

The company also recently disclosed a dividend, which was paid on Sunday, September 15th. Investors of record on Thursday, September 5th were issued a $0.0334 dividend. The ex-dividend date was Wednesday, September 4th. This represents a dividend yield of 1.72%. This is a positive change from BioSyent’s previous dividend of $0.03.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.